Trials / Completed
CompletedNCT02946840
The Use of a New Core Needle in the Endoscopic Ultrasound Assisted Tissue Sampling for Pancreatic Solid Masses
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Istituto Clinico Humanitas · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA) is a reliable, safe, and effective technique for obtaining samples from pancreatic masses. A new core biopsy needle has been developed by Beacon bnx® (Medtronic, Newton, MA) that allows the possibility to achieve a core for histology evaluation and the interchangibility of needle size using the same needle shelter and different needle sizes.
Detailed description
At every pass, the material will be fixed in formalin. Three passes will be done. Details of the aspirated material will be described at macroscopic evaluation by the endoscopist and then by the pathologist at macroscopic and microscopic evaluation, in order to find an interobserved agreement on the definition of the core.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | FNA with 25 G Beacon needle |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2017-05-01
- Completion
- 2018-05-01
- First posted
- 2016-10-27
- Last updated
- 2018-08-08
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02946840. Inclusion in this directory is not an endorsement.